Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 183 articles:
HTML format



Single Articles


    June 2022
  1. DAVAKIS S, Kapelouzou A, Liakakos T, Mpoura M, et al
    The Role of Toll-like Receptors in Esophageal Cancer.
    Anticancer Res. 2022;42:2813-2818.
    PubMed     Abstract available


  2. TAKAHASHI K, Nishikawa K, Tanishima Y, Ishikawa Y, et al
    Risk Stratification of Postoperative Pneumonia in Patients Undergoing Subtotal Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2022;42:3023-3028.
    PubMed     Abstract available


  3. BOOKA E, Kikuchi H, Haneda R, Soneda W, et al
    Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer.
    Anticancer Res. 2022;42:2977-2987.
    PubMed     Abstract available


  4. RADES D, Warwas B, Cremers F, Gerull K, et al
    The First Prognostic Tool to Estimate the Risk of Late Grade >/=3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer.
    Anticancer Res. 2022;42:3035-3039.
    PubMed     Abstract available


  5. ITO K, Ishida H, Fujishima F, Nakamura Y, et al
    Murine Double Minute 2 Antagonist Nutlin-3 Enhanced Chemosensitivity in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2875-2882.
    PubMed     Abstract available


  6. MATSUKI T, Fushimi C, Miyamoto S, Takahashi H, et al
    Preoperative S-1 Therapy for Head and Neck Carcinoma During the Waiting Period Before Surgery.
    Anticancer Res. 2022;42:3177-3183.
    PubMed     Abstract available


  7. MUSIO D, DE Vincentiis M, D'Urso P, Musacchio A, et al
    Hearing Loss After Cisplatin-based Chemoradiotherapy for Locally Advanced Head and Neck Cancer: A Prospective Single-institution Study.
    Anticancer Res. 2022;42:3003-3009.
    PubMed     Abstract available


  8. ENDO M, Nishioka T, Numazaki K, Hasegawa H, et al
    Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2022;42:2931-2937.
    PubMed     Abstract available


    May 2022
  9. SUOJANEN J, Kainulainen S, Tarvainen L, Tornwall J, et al
    Handgrip Strength Predicts Poorly the Surgical Outcome or Length of Hospitalization in Patients With Surgically Operated Oral Cancer.
    Anticancer Res. 2022;42:2771-2774.
    PubMed     Abstract available


  10. OKAMOTO K, Ninomiya I, Saito H, Shimada M, et al
    Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study.
    Anticancer Res. 2022;42:2783-2790.
    PubMed     Abstract available


  11. EMI M, Hmai Y, Yoshikawa T, Hirohata R, et al
    Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2791-2795.
    PubMed     Abstract available


  12. KUNTE S, Sharett J, Wei W, Nasr C, et al
    Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes.
    Anticancer Res. 2022;42:2531-2539.
    PubMed     Abstract available


  13. WARWAS B, Cremers F, Gerull K, Leichtle A, et al
    Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers.
    Anticancer Res. 2022;42:2657-2663.
    PubMed     Abstract available


  14. KATO T, Oshikiri T, Goto H, Sawada R, et al
    Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2775-2782.
    PubMed     Abstract available


  15. ACHILLA C, Papavramidis T, Angelis L, Chatzikyriakidou A, et al
    The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer.
    Anticancer Res. 2022;42:2261-2276.
    PubMed     Abstract available


  16. DOLL C, Steffen C, Beck-Broichsitter B, Richter M, et al
    The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases.
    Anticancer Res. 2022;42:2405-2413.
    PubMed     Abstract available


  17. KAJIKAWA H, Hirata M, Haruna M, Ueyama A, et al
    Tumor-infiltrating ICOS(+) Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' Tumor.
    Anticancer Res. 2022;42:2383-2393.
    PubMed     Abstract available


  18. AOYAMA T, Ju M, Komori K, Tamagawa H, et al
    The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
    Anticancer Res. 2022;42:2711-2717.
    PubMed     Abstract available


  19. WONGPANUWICH W, Yodsanga S, Chaisuparat R, Amornphimoltham P, et al
    Association Between PD-L1 and Histatin1, 3 Expression in Advanced Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2689-2699.
    PubMed     Abstract available


  20. KLIMAITE R, Kazokaite M, Kondrotiene A, Dauksiene D, et al
    Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer.
    Anticancer Res. 2022;42:2289-2299.
    PubMed     Abstract available


  21. HUANG TS, Lee JJ, Huang SY, Cheng SP, et al
    Regulation of Expression of Sterol Regulatory Element-binding Protein 1 in Thyroid Cancer Cells.
    Anticancer Res. 2022;42:2487-2493.
    PubMed     Abstract available


    April 2022
  22. TAKAKUSAGI Y, Kano K, Shima S, Tsuchida K, et al
    Clinical Outcomes of Radiotherapy in Elderly and Younger Patients With T4 Esophageal Cancer: A Retrospective Single-center Analysis.
    Anticancer Res. 2022;42:2095-2104.
    PubMed     Abstract available


  23. REMSCHMIDT B, Pau M, Gaessler J, Zemann W, et al
    Diabetes Mellitus and Oral Cancer: A Retrospective Study from Austria.
    Anticancer Res. 2022;42:1899-1903.
    PubMed     Abstract available


  24. MAYO ZS, Ilori EO, Matia B, Smile TD, et al
    Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.
    Anticancer Res. 2022;42:1845-1849.
    PubMed     Abstract available


  25. TSUTSUMI S, Momiyama K, Ichinoe M, Kato T, et al
    The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2061-2070.
    PubMed     Abstract available


    March 2022
  26. SUZUKI H, Yokoi M, Hagiwara S, Sasaki E, et al
    A Case of Salvage Maxillectomy for Recurrent Oral Cancer After Boron Neutron Capture Therapy During the COVID-19 Pandemic.
    Anticancer Res. 2022;42:1653-1657.
    PubMed     Abstract available


  27. ITO T, Okamoto I, Tokashiki K, Sato H, et al
    PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated Head-and-Neck Cancer.
    Anticancer Res. 2022;42:1547-1554.
    PubMed     Abstract available


  28. OKADA T, Fushimi C, Matsuki T, Okamoto I, et al
    Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:1607-1613.
    PubMed     Abstract available


  29. OHSAWA M, Hamai Y, Emi M, Ibuki Y, et al
    Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Recurrence and Prognosis in Oesophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:1499-1507.
    PubMed     Abstract available


  30. LIU A, Borges PM, Tay YS, Thompson LDR, et al
    Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of PTEN Hamartoma Tumor Syndrome in an Adult Patient With a Novel RECQL4 Mutation.
    Anticancer Res. 2022;42:1481-1485.
    PubMed     Abstract available


  31. CLAUSEN S, Falk M, Oesterling F, Fehr A, et al
    Outcome of Ordinary Polymorphous Adenocarcinomas of the Salivary Glands in Comparison With Papillary and Cribriform Subtypes.
    Anticancer Res. 2022;42:1455-1463.
    PubMed     Abstract available


  32. MUSHA A, Kubo N, Kawamura H, Okano N, et al
    Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study.
    Anticancer Res. 2022;42:1439-1446.
    PubMed     Abstract available


  33. JIN MC, Qian ZJ, Megwalu UC
    Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer.
    Anticancer Res. 2022;42:1359-1365.
    PubMed     Abstract available


    February 2022
  34. URAKAWA N, Kanaji S, Suzuki S, Sawada R, et al
    Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma.
    Anticancer Res. 2022;42:1051-1057.
    PubMed     Abstract available


  35. HASHIMOTO K, Yasumatsu R, Kuga R, Hongo T, et al
    Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma.
    Anticancer Res. 2022;42:981-989.
    PubMed     Abstract available


  36. DAVAKIS S, Charalabopoulos A, Kyros E, Sakarellos P, et al
    Minimally Invasive Transcervical Esophagectomy With Mediastinal Lymphadenectomy for Cancer. A Comparison With Standardized Techniques.
    Anticancer Res. 2022;42:675-680.
    PubMed     Abstract available


    January 2022
  37. RUDHART SA, Langen P, Thangavelu K, Gehrt F, et al
    Clinical Impact of CYFRA 21-1 a Marker for Treatment Failure in Patients With Oropharyngeal Cancer Treated by Radio(chemo)therapy.
    Anticancer Res. 2022;42:137-146.
    PubMed     Abstract available


  38. VEGH A, Banyai D, Ujpal M, Somogyi KS, et al
    Prevalence of Diabetes and Impaired Fasting Glycemia in Patients With Oral Cancer: A Retrospective Study in Hungary.
    Anticancer Res. 2022;42:109-113.
    PubMed     Abstract available


  39. ALSHARIF U, Steller D, Falougy M, Tharun L, et al
    The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1).
    Anticancer Res. 2022;42:97-104.
    PubMed     Abstract available


  40. AL-JUMAYLI M, Choucair K, Al-Obaidi A, Park R, et al
    Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer.
    Anticancer Res. 2022;42:59-66.
    PubMed     Abstract available


  41. KONISHI M, Takeuchi Y, Kubo K, Imano N, et al
    Reirradiation Using (198)Au Grain Brachytherapy for Recurrent Oral Cancer Cases Previously Treated by Definitive Radiotherapy.
    Anticancer Res. 2022;42:293-300.
    PubMed     Abstract available


  42. YOSHIDA T, Nishino T, Goto M, Inoue S, et al
    ypN0 in Patients With Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer.
    Anticancer Res. 2022;42:195-203.
    PubMed     Abstract available


  43. KAMADA T, Ohdaira H, Ito E, Fuse Y, et al
    Preoperative Masseter Muscle Sarcopenia Predicts Mortality in Patients With Oesophageal Cancer.
    Anticancer Res. 2022;42:301-310.
    PubMed     Abstract available


  44. KONISHI M, Fujita M, Shimabukuro K, Wongratwanich P, et al
    Predictive Factors of Late Cervical Lymph Node Metastasis Using Intraoral Sonography in Patients With Tongue Cancer.
    Anticancer Res. 2022;42:287-292.
    PubMed     Abstract available


  45. TOYA R, Watakabe T, Murakami D, Matsuyama T, et al
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation.
    Anticancer Res. 2022;42:205-209.
    PubMed     Abstract available


    December 2021
  46. YOSHINO K, Okamoto I, Sato H, Okada T, et al
    Effect of Concomitant Lafutidine on Adjuvant S-1 for Head and Neck Cancer: A Comparative Study.
    Anticancer Res. 2021;41:6279-6285.
    PubMed     Abstract available


  47. HAMAI Y, Hihara J, Emi M, Ibuki Y, et al
    Prospective Randomized Trial of Early Postoperative Enteral and Total Parenteral Nutrition for Treating Esophageal Cancer.
    Anticancer Res. 2021;41:6237-6246.
    PubMed     Abstract available


  48. YOSHIMURA RI, Toda K, Watanabe H, Kaida A, et al
    Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer.
    Anticancer Res. 2021;41:6259-6266.
    PubMed     Abstract available


  49. YUE CH, Chen CH, Pan YR, Chen YP, et al
    Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-beta/Smad/miR-181b/TIMP3 Signaling Pathway.
    Anticancer Res. 2021;41:6095-6104.
    PubMed     Abstract available


  50. NAKAMURA S, Mukudai Y, Chikuda J, Zhang M, et al
    Combinational Anti-tumor Effects of Chemicals from Paeonia lutea Leaf Extract in Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2021;41:6077-6086.
    PubMed     Abstract available


  51. HARADA K, Ferdous T, Mishima K
    Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells.
    Anticancer Res. 2021;41:6039-6049.
    PubMed     Abstract available


    November 2021
  52. BABA D, Fushimi C, Hanyu K, Masubuchi T, et al
    Prognostic Factors of Potential Early Recurrence of Hypopharyngeal Carcinoma.
    Anticancer Res. 2021;41:5761-5766.
    PubMed     Abstract available


  53. WU J, Galvan KJ, Bogard RD, Peterson CE, et al
    DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer.
    Anticancer Res. 2021;41:5393-5403.
    PubMed     Abstract available


  54. JOGIAT U, Grant C, Bedard ELR, Au K, et al
    Esophageal Adenocarcinoma Metastasizing to a Solitary Fibrous Tumor: An Unprecedented Case of Tumor-to-tumor Metastasis.
    Anticancer Res. 2021;41:5835-5838.
    PubMed     Abstract available


  55. NARUSE T, Yanamoto S, Otsuru M, Yamakawa N, et al
    Multicenter Retrospective Study of Weekly Cetuximab Plus Paclitaxel for Recurrent or Metastatic Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:5785-5791.
    PubMed     Abstract available


  56. NA YM, Cho JS, Park MH
    Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Anticancer Res. 2021;41:5713-5721.
    PubMed     Abstract available


  57. ALSHARIF U, Hofmann M, Gebhard M, Tharun L, et al
    Double Positivity for HPV DNA/P16(INK4a) Does Not Influence Survival of Patients With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:5557-5568.
    PubMed     Abstract available


  58. CIERPIKOWSKI P, Lis-Nawara A, Bar J
    SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:5405-5413.
    PubMed     Abstract available


    October 2021
  59. HUANG YH, Hung YS, Lai CC, Ho MM, et al
    Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy.
    Anticancer Res. 2021;41:5213-5222.
    PubMed     Abstract available


  60. RADES D, Kopelke S, Soror T, Bartscht T, et al
    Risk Factors for Sleep Disturbances in Patients Scheduled for Radiotherapy of Head-and-Neck Cancer.
    Anticancer Res. 2021;41:5065-5069.
    PubMed     Abstract available


  61. IMAIZUMI T, Matsuda K, Tanaka K, Kondo H, et al
    Detection of Endogenous DNA Double-strand Breaks in Oral Squamous Epithelial Lesions by P53-binding Protein 1.
    Anticancer Res. 2021;41:4771-4779.
    PubMed     Abstract available


  62. EISMANN J, Elsayad K, Rolf D, Sarif I, et al
    Intensity-modulated Radiotherapy in Patients With Aggressive Extranodal Non-Hodgkin Lymphoma of the Head and Neck.
    Anticancer Res. 2021;41:5131-5135.
    PubMed     Abstract available


  63. LANDSTROM F, Aspenblad E, Reizenstein J, Kristiansson S, et al
    The Value of Post-treatment Surveillance for Detection of Loco-regional Recurrences in Oral Tongue Cancer.
    Anticancer Res. 2021;41:5059-5063.
    PubMed     Abstract available


  64. DOMB C, Smile TD, Reddy C, Woody NM, et al
    Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and Neck.
    Anticancer Res. 2021;41:4995-5000.
    PubMed     Abstract available


    September 2021
  65. SAKAI M, Sohda M, Uchida S, Yamaguchi A, et al
    Fibrin/fibrinogen Degradation Products Are Associated With Tumor Stage and Prognosis in Patients Undergoing Resection of Esophageal Cancer.
    Anticancer Res. 2021;41:4523-4527.
    PubMed     Abstract available


  66. KAWASAKI M, Sakabe T, Kodani I, Umekita Y, et al
    Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4563-4570.
    PubMed     Abstract available


  67. KOIKE K, Nishiyama K, Dehari H, Ogi K, et al
    Prognostic Value of CD45Ro(+) T-Cell Expression in Patients With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4515-4522.
    PubMed     Abstract available


    August 2021
  68. AGAWA K, Yamashita K, Nakagawa A, Yamada K, et al
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4117-4126.
    PubMed     Abstract available


  69. TOKASHIKI K, Okamoto I, Okada T, Sato H, et al
    Postoperative Complications of Jejunal and Skin Valve Reconstruction in Free Reconstructive Surgery for Hypopharyngeal Carcinoma.
    Anticancer Res. 2021;41:4033-4038.
    PubMed     Abstract available


  70. LANDSTROM F, Kristiansson S, Reizenstein J
    The Role of Electrochemotherapy in Curative Treatment of Head and Neck Cancer and Advanced Skin Cancer: A Need for New Treatment Protocols?
    Anticancer Res. 2021;41:3977-3982.
    PubMed     Abstract available


  71. YAMASHITA K, Miyazaki Y, Nakatani D, Masuike Y, et al
    OSK-0028 in Patients With Esophageal Cancer Undergoing Esophagectomy: A Double-blind, Randomised Controlled Trial.
    Anticancer Res. 2021;41:3875-3884.
    PubMed     Abstract available


  72. DE OLIVEIRA NETO CP, Brito HO, DA Costa RMG, Brito LMO, et al
    Is There a Role for Sex Hormone Receptors in Head-and-neck Cancer? Links with HPV Infection and Prognosis.
    Anticancer Res. 2021;41:3707-3716.
    PubMed     Abstract available


  73. SAKAI M, Sohda M, Uchida S, Yamaguchi A, et al
    Combining Preoperative Immunoinflammatory Scores and (18)F-Fluorodeoxyglucose Positron-emission Tomography Predicts Beneficiaries of Salvage Esophagectomy.
    Anticancer Res. 2021;41:4005-4011.
    PubMed     Abstract available


  74. WU TK, Ou YC, Chen YP, Huang FM, et al
    Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
    Anticancer Res. 2021;41:3789-3799.
    PubMed     Abstract available


    July 2021
  75. CAO C, Poti SM, Ledgerwood LG, Lai J, et al
    Mixed HPV-related Neuroendocrine Carcinoma and HPV-related Squamous Cell Carcinoma of the Base of Tongue in a Patient With Incidental Identification of Synchronous Metastatic Papillary Thyroid Carcinoma.
    Anticancer Res. 2021;41:3639-3642.
    PubMed     Abstract available


  76. LANDSTROM F, Kristiansson S, Appelros P
    Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area.
    Anticancer Res. 2021;41:3519-3522.
    PubMed     Abstract available


  77. KNITTER S, Andreou A, Hofmann T, Chopra S, et al
    Minimally Invasive Versus Open Ivor-Lewis Esophagectomy for Esophageal Cancer or Cancer of the Gastroesophageal Junction: Comparison of Postoperative Outcomes and Long-term Survival Using Propensity Score Matching Analysis.
    Anticancer Res. 2021;41:3499-3510.
    PubMed     Abstract available


  78. LUNDIN E, Reizenstein J, Landstrom F, Bergqvist M, et al
    Radiotherapy as Elective Treatment of the Node-negative Neck in Oral Squamous Cell Cancer.
    Anticancer Res. 2021;41:3489-3498.
    PubMed     Abstract available


  79. FUJITA J, Nakajima M, Muroi H, Kikuchi M, et al
    The Prognostic Significance of Plakophilin-1 Expression in Esophageal Cancer.
    Anticancer Res. 2021;41:3401-3407.
    PubMed     Abstract available


  80. KII T, Sakuma K, Tanaka A
    PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:3363-3370.
    PubMed     Abstract available


  81. HYAKUSOKU H, Sawakuma K, Sano D, Takahashi H, et al
    FosL1 Regulates Regional Metastasis of Head and Neck Squamous Cell Carcinoma by Promoting Cell Migration, Invasion, and Proliferation.
    Anticancer Res. 2021;41:3317-3326.
    PubMed     Abstract available


    June 2021
  82. STAACKMANN C, Ribbat-Idel J, Perner S, Idel C, et al
    Palliative Local Radiotherapy for Advanced Squamous Cell Carcinoma of the Head-and-Neck: Prognostic Factors of Survival.
    Anticancer Res. 2021;41:3205-3210.
    PubMed     Abstract available


  83. HAMAI Y, Emi M, Ibuki Y, Kurokawa T, et al
    Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy.
    Anticancer Res. 2021;41:3011-3021.
    PubMed     Abstract available


  84. KYRODIMOS E, Chrysovergis A, Mastronikolis N, Tsiambas E, et al
    Impact of Topoisomerases Complex Deregulation on Head and Neck Carcinoma Genomic Instability.
    Anticancer Res. 2021;41:2773-2779.
    PubMed     Abstract available


  85. RADES D, Staackmann C, Ribbat-Idel J, Perner S, et al
    A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-Neck.
    Anticancer Res. 2021;41:3055-3058.
    PubMed     Abstract available


  86. SARMA D, Karna R, Nasrullah A, Zhang Q, et al
    Primary Esophageal Small Cell Carcinoma Masquerading as Non-Hodgkin Lymphoma in a Young Patient.
    Anticancer Res. 2021;41:3023-3027.
    PubMed     Abstract available


  87. OKUHATA K, Monzen H, Tamura M, Matsumoto K, et al
    Plan Complexity and Delivery Accuracy of Knowledge-based Volumetric Modulated Arc Therapy Plans with Single Optimization for Oropharyngeal Cancer.
    Anticancer Res. 2021;41:2925-2931.
    PubMed     Abstract available


    May 2021
  88. RADES D, Staackmann C, Schild SE
    Karnofsky Performance Score - An Independent Prognostic Factor of Survival After Palliative Irradiation for Sino-nasal Cancer.
    Anticancer Res. 2021;41:2495-2499.
    PubMed     Abstract available


  89. HAAG A, Huffman D, Peterson C, Shankar K, et al
    Cutaneous Lesion of the Nose as Initial Presentation of Esophageal Adenocarcinoma.
    Anticancer Res. 2021;41:2485-2488.
    PubMed     Abstract available


  90. IWASAKI T, Onda T, Honda H, Hayashi K, et al
    Over-expression of PDE5 in Oral Squamous Cell Carcinoma - Effect of Sildenafil Citrate.
    Anticancer Res. 2021;41:2297-2306.
    PubMed     Abstract available


    April 2021
  91. YU WN, Lin HF, Lee YI, Shia WC, et al
    PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study.
    Anticancer Res. 2021;41:2177-2182.
    PubMed     Abstract available


  92. SAKAI M, Sohda M, Saito H, Nakazawa N, et al
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting.
    Anticancer Res. 2021;41:2141-2145.
    PubMed     Abstract available


  93. FRIEDRICH RE, Scheuer HT, Zustin J, Luebke AM, et al
    Microdont Developing Outside the Alveolar Process and Within Oral Diffuse and Plexiform Neurofibroma in Neurofibromatosis Type 1.
    Anticancer Res. 2021;41:2083-2092.
    PubMed     Abstract available


  94. SUZUKI M, Takenaka Y, Kishikawa T, Yamamoto Y, et al
    Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer.
    Anticancer Res. 2021;41:2045-2051.
    PubMed     Abstract available


  95. TAKAKUSAGI Y, Kusunoki T, Kano K, Anno W, et al
    Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer.
    Anticancer Res. 2021;41:1951-1958.
    PubMed     Abstract available


  96. FUKUDA M, Ogasawara Y, Hayashi H, Okuyama A, et al
    Down-regulation of Glutathione Peroxidase 4 in Oral Cancer Inhibits Tumor Growth Through SREBP1 Signaling.
    Anticancer Res. 2021;41:1785-1792.
    PubMed     Abstract available


  97. PAWLICZAK J, Kolb M, Bauer M, Gminski R, et al
    Micronucleus Formation in Primary Oropharyngeal Epithelial Cells Reveals Mutagenicity of Cement Dusts.
    Anticancer Res. 2021;41:1849-1858.
    PubMed     Abstract available


  98. HOTTA H, Hamamura K, Shibuya H, Ohmi Y, et al
    Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling.
    Anticancer Res. 2021;41:1821-1830.
    PubMed     Abstract available


  99. OGO A, Miyake S, Kubota H, Higashida M, et al
    The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
    Anticancer Res. 2021;41:1771-1778.
    PubMed     Abstract available


  100. KOERDT S, Raguse JD, Neumann F, Beck-Broichsitter B, et al
    Value of Panendoscopy in the Identification of Synchronous Malignancies in Patients Suffering from Oral Squamous Cell Carcinoma Without Clinical Signs of a Second Primary Tumor.
    Anticancer Res. 2021;41:2039-2044.
    PubMed     Abstract available


    March 2021
  101. MARCHAND-CRETY C, Pascard M, Debreuve-Theresette A, Ettalhaoui L, et al
    Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry.
    Anticancer Res. 2021;41:1555-1561.
    PubMed     Abstract available


  102. FUKUDA N, Toda K, Ohmoto A, Wang X, et al
    Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Anticancer Res. 2021;41:1683-1691.
    PubMed     Abstract available


  103. OWIN N, Elsayad K, Rolf D, Haverkamp U, et al
    Radiotherapy as Part of Treatment Strategies in Nasal Cavity and Paranasal Sinus Malignancies.
    Anticancer Res. 2021;41:1587-1592.
    PubMed     Abstract available


  104. KURIYAMA K, Sohda M, Watanabe T, Saito H, et al
    Resistance to Preoperative Oral Care Is Associated With Postoperative Pneumonia After Oesophageal Cancer Surgery.
    Anticancer Res. 2021;41:1507-1514.
    PubMed     Abstract available


  105. FRANZEN AM, Windfuhr JP
    Tonsillectomy as a Prevention Strategy in the Light of Increasing Incidence of Oropharyngeal Cancer - a Research of Current Literature.
    Anticancer Res. 2021;41:1157-1161.
    PubMed     Abstract available


    February 2021
  106. MENG X, Matsumoto F, Mori T, Miura N, et al
    BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:1089-1099.
    PubMed     Abstract available


  107. MEIROVITZ A, Gross M, Leibovici V, Sheva K, et al
    Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients.
    Anticancer Res. 2021;41:1083-1087.
    PubMed     Abstract available


  108. NISHII N, Hirotsu Y, Koida N, Takahashi Y, et al
    Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers.
    Anticancer Res. 2021;41:1035-1040.
    PubMed     Abstract available


  109. TADA H, Takahashi H, Ida S, Mito I, et al
    The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:885-893.
    PubMed     Abstract available


  110. RADES D, Narvaez CA, Janssen S, SchrOder U, et al
    Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer.
    Anticancer Res. 2021;41:877-884.
    PubMed     Abstract available


  111. LEE HP, Tsai KW, Lee CC
    Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer.
    Anticancer Res. 2021;41:803-810.
    PubMed     Abstract available


  112. INOUE M, Takeuchi H, Matsuda S, Nishi T, et al
    IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis.
    Anticancer Res. 2021;41:783-794.
    PubMed     Abstract available


  113. UEDA S, Goto M, Hashimoto K, Imazawa M, et al
    Salivary CPLANE1 Levels as a Biomarker of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:765-772.
    PubMed     Abstract available


  114. JIANG C, Lee SH, Park JH, Lee JS, et al
    A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
    Anticancer Res. 2021;41:687-697.
    PubMed     Abstract available


    January 2021
  115. NARVAEZ CA, Schild SE, Janssen S, Schroeder U, et al
    Accelerated Fractionation With Concomitant Boost vs. Conventional Radio-chemotherapy for Definitive Treatment of Locally Advanced Squamous Cell Carcinoma of the Head-and-Neck (SCCHN).
    Anticancer Res. 2021;41:477-484.
    PubMed     Abstract available


  116. SOHDA M, Miyazaki T, Watanabe T, Nakazawa N, et al
    Utility of Thermography of Reconstructed Gastric Conduit for Predicting Postoperative Anastomotic Leakage After Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2021;41:453-458.
    PubMed     Abstract available


  117. SASAKI K, Osako Y, Urata M, Noda M, et al
    Clinical Outcomes of Fully Covered Self-expanding Metallic Stent Placement for Palliation of Incurable Esophageal Cancer With or Without Radiotherapy.
    Anticancer Res. 2021;41:385-389.
    PubMed     Abstract available


  118. ZHANG H, Yi J, Kim E, Choo Y, et al
    20(S)-Ginsenoside Rh2 Suppresses Oral Cancer Cell Growth by Inhibiting the Src-Raf-ERK Signaling Pathway.
    Anticancer Res. 2021;41:227-235.
    PubMed     Abstract available


  119. WILHELM C, Hackenberg S, Bregenzer M, Meyer T, et al
    Effect of Hypoxia on Proliferation and the Expression of the Genes HIF-1alpha and JMJD1A in Head and Neck Squamous Cell Carcinoma Cell Lines.
    Anticancer Res. 2021;41:113-122.
    PubMed     Abstract available


  120. KOUKOURAKIS IM, Zygogianni A, Kouloulias V, Kyrgias G, et al
    Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?
    Anticancer Res. 2021;41:467-475.
    PubMed     Abstract available


  121. STARK CR, Gustavsson I, Horal P, Kotopouli M, et al
    Brush Samples of Oral Lesions to FTA Elute Card for High-risk Human Papilloma Virus Diagnosis.
    Anticancer Res. 2021;41:269-277.
    PubMed     Abstract available


  122. LAI KC, Chia YT, Yih LH, Lu YL, et al
    Antitumor Effects of the Novel Quinazolinone Holu-12: Induction of Mitotic Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma CAL27 Cells.
    Anticancer Res. 2021;41:259-268.
    PubMed     Abstract available


  123. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Spyropoulou D, et al
    Comparative E-Cadherin Digital Expression Analysis in HPV and non-HPV Related Squamous Cell Carcinoma of the Oral Cavity.
    Anticancer Res. 2021;41:163-167.
    PubMed     Abstract available


  124. FURUKAWA K, Kawasaki G, Yoshida T, Umeda M, et al
    Clinicopathological and Prognostic Analysis of PD-L1 and PD-L2 Expression in Surgically Resected Primary Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:101-111.
    PubMed     Abstract available


  125. UCHI R, Jiromaru R, Yasumatsu R, Yamamoto H, et al
    Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma.
    Anticancer Res. 2021;41:71-79.
    PubMed     Abstract available


    December 2020
  126. SUGIURA K, Nakajima S, Kato I, Okubo-Sato M, et al
    Hypoxia and CD11b+ Cell Influx Are Strongly Associated With Lymph Node Metastasis of Oral Cancer.
    Anticancer Res. 2020;40:6845-6852.
    PubMed     Abstract available


  127. LIU B, Shiraga S, Mortenson MM, Lai J, et al
    Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:7053-7056.
    PubMed     Abstract available


  128. NECKEL N, Michael M, Troeltzsch D, WUster J, et al
    Rediscussing the Role of Traditional Risk Factors in Young Adults With Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:6987-6995.
    PubMed     Abstract available


  129. CHEN CH, Huang YC, Lee YH, Tan ZL, et al
    Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.
    Anticancer Res. 2020;40:6723-6732.
    PubMed     Abstract available


    November 2020
  130. KIM SH, Cho YK, Huh JH, Kang JG, et al
    Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.
    Anticancer Res. 2020;40:6137-6150.
    PubMed     Abstract available


  131. TRUMBULL D, Lemini R, Attwood K, Kukar M, et al
    Gastric Cancer Disparities Among Asian American Subpopulations.
    Anticancer Res. 2020;40:6381-6385.
    PubMed     Abstract available


  132. DE JESUS OLIVEIRA KATO V, DE Abreu MC, DE Brito Kato AM, DE Souza LL, et al
    Significance of P16(INK4A) Expression and PTEN Loss of Heterozygosity in Human Papilloma Virus-related Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:6355-6366.
    PubMed     Abstract available


  133. SUNG ES, Kim JY, Ahn YT, Lee IW, et al
    Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.
    Anticancer Res. 2020;40:6295-6303.
    PubMed     Abstract available


  134. BIRK R, Schell A, Aderhold C, Hoch S, et al
    Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC.
    Anticancer Res. 2020;40:6195-6203.
    PubMed     Abstract available


  135. MARUYAMA N, Umikawa M, Matsumoto H, Maruyama T, et al
    miR-935 Inhibits Oral Squamous Cell Carcinoma and Targets Inositol Polyphosphate-4-phosphatase Type IA (INPP4A).
    Anticancer Res. 2020;40:6101-6113.
    PubMed     Abstract available


  136. PELTONEN J, Tuomainen K, Sallinen T, Faress I, et al
    Effect of Sex Steroid Hormones on Tongue Cancer Cells In Vitro.
    Anticancer Res. 2020;40:6029-6037.
    PubMed     Abstract available


    October 2020
  137. KAWAKITA Y, Motoyama S, Sato Y, Wakita A, et al
    Prognostic Significance of Combined Platelet Distribution Width and C-Reactive Protein Score in Esophageal Cancer.
    Anticancer Res. 2020;40:5715-5725.
    PubMed     Abstract available


  138. SHIH LC, Tsai CW, Chang WS, Shen TC, et al
    Association of Caspase-8 Genotypes With the Risk for Nasopharyngeal Carcinoma in Taiwan.
    Anticancer Res. 2020;40:5503-5508.
    PubMed     Abstract available


  139. KOENIGSBERG C, Ondrey FG
    Genomic Database Analysis for Head and Neck Cancer Prevention Targets: MTOR Signal Transduction Pathway.
    Anticancer Res. 2020;40:5417-5421.
    PubMed     Abstract available


  140. TAKAGI K, Buettner S, Ijzermans JNM, Wijnhoven BPL, et al
    Systematic Review on the Controlling Nutritional Status (CONUT) Score in Patients Undergoing Esophagectomy for Esophageal Cancer.
    Anticancer Res. 2020;40:5343-5349.
    PubMed     Abstract available


  141. HAAG A, Jayakrishnan T, Shah D, Sandhu A, et al
    First Reported Case of Localized Extra-pulmonary Small Cell Carcinoma (EPSC) of the Esophagus Treated With Triple Therapy.
    Anticancer Res. 2020;40:5919-5923.
    PubMed     Abstract available


  142. TANISHIMA Y, Nishikawa K, Arakawa Y, Matsumoto A, et al
    Five-year Outcomes of Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Oesophagectomy in Oesophageal Cancer.
    Anticancer Res. 2020;40:5829-5835.
    PubMed     Abstract available


  143. KUVENDJISKA J, Pitman MB, Martini V, Braun C, et al
    Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
    Anticancer Res. 2020;40:5679-5685.
    PubMed     Abstract available


  144. HUBER L, Birk R, Knuettel M, Rotter N, et al
    FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus.
    Anticancer Res. 2020;40:5621-5630.
    PubMed     Abstract available


    September 2020
  145. FUSHIMI C, Okamoto I, Matsuki T, Masubuchi T, et al
    Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma.
    Anticancer Res. 2020;40:5277-5283.
    PubMed     Abstract available


  146. KUBOTA H, Hirai T, Yamauchi A, Ogo A, et al
    Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
    Anticancer Res. 2020;40:5043-5048.
    PubMed     Abstract available


  147. TERATANI M, Nakamura S, Sakagami H, Fujise M, et al
    Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro.
    Anticancer Res. 2020;40:4885-4894.
    PubMed     Abstract available


    August 2020
  148. KUROKAWA T, Hamai Y, Emi M, Ibuki Y, et al
    Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy.
    Anticancer Res. 2020;40:4387-4394.
    PubMed     Abstract available


  149. LEE MY, Fowler N, Adelstein D, Koyfman S, et al
    Detection and Oncologic Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary Origin.
    Anticancer Res. 2020;40:4207-4214.
    PubMed     Abstract available


  150. TSUCHIHASHI K, Nakatsugawa M, Kobayashi JI, Sasaya T, et al
    Borderline Microenvironment Fibrosis Is a Novel Poor Prognostic Marker of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4319-4326.
    PubMed     Abstract available


    July 2020
  151. KUBO K, Murakami Y, Imano N, Takeuchi Y, et al
    A Single Institution's Experience of Definitive Radiotherapy Using Volumetric-modulated Arc Therapy for Hypopharyngeal Cancers.
    Anticancer Res. 2020;40:4183-4190.
    PubMed     Abstract available


  152. JEONG JY, Park TI, Ahn D
    Comprehensive Analysis and Clinical Implication of PD-L1 Expression Considering HPV Status in Oropharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:4001-4010.
    PubMed     Abstract available


  153. KOMATSU N, Komatsu M, Ohashi R, Horii A, et al
    Photosensitizer With Illumination Enhances In Vivo Antitumor Effect of Anti-ROBO1 Immunotoxin on Maxillary Sinus Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3793-3799.
    PubMed     Abstract available


  154. CHRYSOVERGIS A, Papanikolaou V, Mastronikolis N, Tsiambas E, et al
    Chromosome 17 In Situ Hybridization Grid-based Analysis in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3759-3764.
    PubMed     Abstract available


  155. LI CH, Shih LC, Hsu CL, Lee HT, et al
    The Contribution of Interleukin-12A Genotypes to Oral Cancer Risk in Taiwanese.
    Anticancer Res. 2020;40:3707-3712.
    PubMed     Abstract available


  156. IIJIMA Y, Bandow K, Amano S, Sano M, et al
    Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
    Anticancer Res. 2020;40:3685-3696.
    PubMed     Abstract available


  157. KRAMER B, Schell A, Aderhold C, Huber L, et al
    Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3847-3855.
    PubMed     Abstract available


  158. CHO JM, Lee HJ, Chung JH, Kim WY, et al
    Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
    Anticancer Res. 2020;40:3801-3809.
    PubMed     Abstract available


    June 2020
  159. TADA H, Takahashi H, Ida S, Nagata Y, et al
    Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:3559-3564.
    PubMed     Abstract available


  160. HIRAKAWA H, Ikegami T, Azechi S, Agena S, et al
    Induction Chemotherapy in Hypopharyngeal Cancer: Influence of DNA Repair Gene Polymorphisms.
    Anticancer Res. 2020;40:3277-3285.
    PubMed     Abstract available


  161. ROSAS R, Buryska S, Silver R, Wuertz B, et al
    Retinoids Augment Thiazolidinedione PPARgamma Activation in Oral Cancer Cells.
    Anticancer Res. 2020;40:3071-3080.
    PubMed     Abstract available


  162. SAMHOURI L, Kriz J, Elsayad K, Channaoui M, et al
    The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era.
    Anticancer Res. 2020;40:3379-3386.
    PubMed     Abstract available


  163. TUNG KL, Wu YT, Liu C, Lin SC, et al
    EBV Rta-induced IL-6 Promotes Migration of Bystander Tumor Cells Through IL-6R/JAK/STAT3 Pathway In Vitro.
    Anticancer Res. 2020;40:3255-3264.
    PubMed     Abstract available


    May 2020
  164. KIDOGAMI S, Iguchi T, Sato K, Yoshikawa Y, et al
    SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2941-2946.
    PubMed     Abstract available


  165. TAKAHASHI K, Osaka Y, Ota Y, Watanabe T, et al
    Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer.
    Anticancer Res. 2020;40:2827-2832.
    PubMed     Abstract available


  166. UTISPAN K, Koontongkaew S
    High Nitric Oxide Adaptation in Isogenic Primary and Metastatic Head and Neck Cancer Cells.
    Anticancer Res. 2020;40:2657-2665.
    PubMed     Abstract available


  167. KANGBOONRUANG K, Wongtrakoongate P, Lertsuwan K, Khachonkham S, et al
    MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin.
    Anticancer Res. 2020;40:2645-2655.
    PubMed     Abstract available


  168. PARK JJ, Hah YS, Ryu S, Cheon SY, et al
    Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells Via Epithelial-to-Mesenchymal Transition.
    Anticancer Res. 2020;40:2627-2635.
    PubMed     Abstract available


  169. AHN SH, Song S, Kim S
    Adjuvant Postoperative CD40 Agonist and PD-1 Antagonist Combination Therapy in Syngeneic Tongue Cancer Mouse Model.
    Anticancer Res. 2020;40:2707-2713.
    PubMed     Abstract available


  170. OAK ASW, Bocheva G, Kim TK, Brozyna AA, et al
    Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/beta-Catenin Pathways.
    Anticancer Res. 2020;40:2467-2474.
    PubMed     Abstract available


    April 2020
  171. KOMORI MF, Kimura T, Kariya S, Onoda T, et al
    Epidemiological Correlations Between Head and Neck Cancer and Hepatitis B Core Antibody Positivity.
    Anticancer Res. 2020;40:2393-2403.
    PubMed     Abstract available


  172. LIN CY, Fang HY, Lein MY, Lin CC, et al
    Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
    Anticancer Res. 2020;40:2387-2392.
    PubMed     Abstract available


  173. TAMAGAWA H, Aoyama T, Tamagawa A, Komori K, et al
    Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Anticancer Res. 2020;40:2365-2371.
    PubMed     Abstract available


  174. AOYAMA T, Atsumi Y, Hara K, Kazama K, et al
    Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation Treatment.
    Anticancer Res. 2020;40:2359-2364.
    PubMed     Abstract available


  175. EGGERSMANN TK, Baumeister P, Kumbrink J, Mayr D, et al
    Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Anticancer Res. 2020;40:2117-2123.
    PubMed     Abstract available


  176. TOYA R, Saito T, Matsuyama T, Kai Y, et al
    Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2073-2077.
    PubMed     Abstract available


  177. YAMAMOTO T, Niibe Y, Matsumoto Y, Dekura Y, et al
    Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.
    Anticancer Res. 2020;40:2065-2072.
    PubMed     Abstract available


  178. TAKAHASHI M, Fukuda K, Saikawa Y, Nakamura R, et al
    Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:1921-1930.
    PubMed     Abstract available


  179. INSODAITE R, Liutkevicius V, Uloza V, Solovejute R, et al
    Association Between MMP8 Gene Polymorphisms and Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:2003-2009.
    PubMed     Abstract available


  180. SHIMODA Y, Yamada T, Komori K, Watanabe H, et al
    Effect of Muscle Mass Loss After Esophagectomy on Prognosis of Oesophageal Cancer.
    Anticancer Res. 2020;40:2275-2281.
    PubMed     Abstract available


    March 2020
  181. KIM HJ, Lee HJ, Jung JH, Kim WW, et al
    Ultrasound Assessment of Synchronous Thyroid Nodules in Patients With Papillary Thyroid Cancer: A Nodule-by-nodule Analysis Between Ultrasound and Pathology.
    Anticancer Res. 2020;40:1779-1786.
    PubMed     Abstract available


  182. VITOLO V, Barcellini A, Mirandola A, Facoetti A, et al
    Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?
    Anticancer Res. 2020;40:1645-1649.
    PubMed     Abstract available


  183. SAITO M, Fujita Y, Kuribayashi N, Uchida D, et al
    Troglitazone, a Selective Ligand for PPARgamma, Induces Cell-cycle Arrest in Human Oral SCC Cells.
    Anticancer Res. 2020;40:1247-1254.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: